EGFR-TKIs Combine With Anlotinib as First-line Treatment for Patients With Advanced EGFR Mutation-positive NSCLC

Conditions

• EGFR Gene Mutation

Interventions

• DRUG: erlotinib or gefitinib or icotinib
• DRUG: Anlotinib

Sponsor

Fujian Cancer Hospital